Latest stories on PTCT
PTC THERAPEUTICS, INC. (PTCT) files 8-K
SEC 8-K50 · neutralgeneral
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
PR Newswire71 · bullishearnings
PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026
PR Newswire50 · neutralgeneral
What This PTC Therapeutics Insider Sale Means as Product Revenue Hit $226 Million
The Motley Fool42 · neutralgeneral
The Prognosis For PTC Therapeutics
Seeking Alpha73 · bullishproduct/pr
PTC Therapeutics Completes Major Convertible Notes Offering
TipRanks28 · bearishgeneral
PTC THERAPEUTICS, INC. (PTCT) files 8-K
SEC 8-K50 · neutralgeneral
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire50 · neutralgeneral
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PTCT Stock News
StockTitan50 · neutralgeneral
PTC Therapeutics Prices New 0% Convertible Senior Notes
TipRanks24 · bearishgeneral
PTC THERAPEUTICS, INC. (PTCT) files 8-K
SEC 8-K50 · neutralgeneral
PTC Therapeutics prices convertible notes for refinancing
Seeking Alpha28 · bearishgeneral
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
PR Newswire28 · bearishgeneral
PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes
PR Newswire28 · bearishgeneral
PTC Therapeutics Director Resigns, Moves to Advisory Role
TipRanks50 · neutralgeneral
PTC THERAPEUTICS, INC. (PTCT) files 8-K
SEC 8-K50 · neutralgeneral
PTC Therapeutics, Inc. (PTCT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
PTC THERAPEUTICS, INC. (PTCT) files 8-K
SEC 8-K50 · neutralgeneral
PTC Therapeutics upgraded at Jefferies on Sephience
Seeking Alpha61 · neutralanalyst
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
PR Newswire63 · neutralearnings